UK markets closed

ACADIA Pharmaceuticals Inc. (DR6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
14.24-1.57 (-9.90%)
At close: 08:07AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
813,806
726,437
517,235
484,145
441,755
Cost of revenue
62,922
41,638
10,166
19,141
20,550
Gross profit
750,884
684,799
507,069
465,004
421,205
Operating expenses
Research development
342,154
351,619
361,575
239,415
319,130
Selling general and administrative
413,315
406,559
369,090
396,028
388,661
Total operating expenses
755,469
758,178
730,665
635,443
707,791
Operating income or loss
-4,585
-73,379
-223,596
-170,439
-286,586
Total other income/expenses net
550
5,109
3,542
2,329
-997
Income before tax
14,905
-51,036
-213,444
-167,519
-280,973
Income tax expense
16,615
10,250
2,531
351
611
Income from continuing operations
-1,710
-61,286
-215,975
-167,870
-281,584
Net income
-1,710
-61,286
-215,975
-167,870
-281,584
Net income available to common shareholders
-1,710
-61,286
-215,975
-167,870
-281,584
Basic EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Diluted EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Basic average shares
163,114
163,819
161,683
160,493
157,331
Diluted average shares
163,114
163,819
161,683
160,493
157,331